The new synergy is expected to create opportunities to support the convergence of life sciences tools and diagnostics–helping pave the way for greater adoption of personalized medicine.
Read More
The test identifies, carriers of certain CYP2C19 genetic mutations in 1 hour. CYP2C19 is an enzyme that metabolizes commonly-prescribed drugs, including antiarrhythmics, proton pump inhibitors, antidepressants, and antiplatelet drugs.
Read More
The probes will help identify molecular changes in study samples.
Read More
Discover new products on the market for your lab.
Read More
It is a 46-gene prognostic test that offers urologists a more accurate way to determine the aggressiveness of prostate cancer.
Read More